(NBIX) Neurocrine Biosciences - Performance -8.1% in 12m
NBIX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
9.25%
#31 in Peer-Group
Rel. Strength
32.87%
#5107 in Stock-Universe
Total Return 12m
-8.06%
#66 in Peer-Group
Total Return 5y
7.86%
#37 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 42.4 |
| P/E Forward | 24.4 |
| High / Low | USD |
|---|---|
| 52 Week High | 153.29 USD |
| 52 Week Low | 87.54 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 65.29 |
| Buy/Sell Signal +-5 | 0.95 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: NBIX (-8.1%) vs XBI (-7.6%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
10.4% | 76.6% | 81.6% | 23 | 13.8 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-6.77% | -4.62% | 149% | 12.9 | 12 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
9.62% | 0.48% | 57% | 26.8 | 13.9 | 0.97 | 0.60% | 41% |
| BIM PA Biomerieux |
2.27% | 33.8% | 9.65% | 32.6 | 25.6 | 1.54 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.43% | -8.06% | 7.86% | 42.4 | 24.4 | 0.27 | 18.7% | -34.3% |
| PTCT NASDAQ PTC Therapeutics |
13.1% | 44.8% | 4.12% | 7.86 | 6.36 | 0.81 | - | 68% |
| KMDA NASDAQ Kamada |
0.29% | 36.9% | -12% | 24.6 | 20.4 | 0.81 | 48.1% | 3.93% |
| ERF PA Eurofins Scientific SE |
8.57% | 17.2% | 11.2% | 28.9 | 15.1 | 0.63 | -62.1% | -19.3% |
Performance Comparison: NBIX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for NBIX
| Total Return (including Dividends) | NBIX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 3.43% | 7.76% | 1.11% |
| 3 Months | 11.56% | -5.31% | 5.58% |
| 12 Months | -8.06% | -7.58% | 10.51% |
| 5 Years | 7.86% | -18.55% | 109.12% |
| Trend Score (consistency of price movement) | NBIX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 81.3% | 84.2% | 69.9% |
| 3 Months | 73.9% | -2.8% | 69.3% |
| 12 Months | -51.3% | -77.8% | 43.2% |
| 5 Years | 56.3% | -53.5% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #124 | -4.02% | 2.29% |
| 3 Month | #60 | 17.81% | 5.66% |
| 12 Month | #66 | -0.52% | -16.80% |
| 5 Years | #38 | 32.42% | -48.42% |
FAQs
Does Neurocrine Biosciences (NBIX) outperform the market?
No,
over the last 12 months NBIX made -8.06%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.58%.
Over the last 3 months NBIX made 11.56%, while XBI made -5.31%.
Performance Comparison NBIX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
NBIX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.6% | 2.3% | -5.5% | -19% |
| US NASDAQ 100 | QQQ | -0.4% | 2% | -4.7% | -17% |
| German DAX 40 | DAX | 1.6% | 4.2% | -21.9% | -38% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.3% | 4.4% | -7.3% | -20% |
| Hongkong Hang Seng | HSI | -1.1% | -1.6% | -24.5% | -35% |
| India NIFTY 50 | INDA | 1.1% | 4.8% | -4.5% | -7% |
| Brasil Bovespa | EWZ | -3% | 3% | -25.7% | -17% |
NBIX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -0.3% | 2% | -8.3% | -31% |
| Consumer Discretionary | XLY | -0.1% | 5.2% | 4.4% | -26% |
| Consumer Staples | XLP | -0.3% | 3.7% | -7% | -15% |
| Energy | XLE | -6.5% | 0.5% | -9.1% | -11% |
| Financial | XLF | 1% | 6% | -8.3% | -32% |
| Health Care | XLV | -2.6% | -0.9% | -5.1% | -3% |
| Industrial | XLI | 0.4% | 3.1% | -11.1% | -26% |
| Materials | XLB | 0.1% | 2% | -6.3% | -7% |
| Real Estate | XLRE | -1.1% | 2.5% | -6.5% | -21% |
| Technology | XLK | -0.9% | 1.4% | -5.9% | -12% |
| Utilities | XLU | -2% | 2.9% | -13.9% | -29% |
| Aerospace & Defense | XAR | 0.4% | -2.3% | -22.5% | -51% |
| Biotech | XBI | -0.3% | -4.3% | 5.3% | -0% |
| Homebuilder | XHB | 1% | 8.5% | 9.9% | 1% |
| Retail | XRT | 3.3% | 3.6% | 2.4% | -9% |
NBIX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -12.4% | -15.3% | -15.4% | -11% |
| Natural Gas | UNG | 0.1% | 6.1% | -23.8% | 7% |
| Gold | GLD | -4.2% | -2.8% | -35.7% | -55% |
| Silver | SLV | 0.2% | -7.9% | -25.1% | -31% |
| Copper | CPER | 1.9% | 1.7% | -20.4% | -16% |
NBIX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -2.1% | 2.8% | -4.1% | -4% |
| iShares High Yield Corp. Bond | HYG | -1.1% | 2.9% | -9.2% | -17% |